156 related articles for article (PubMed ID: 26583307)
1. COMPARISON OF MANUAL AND SEMIAUTOMATED FUNDUS AUTOFLUORESCENCE ANALYSIS OF MACULAR ATROPHY IN STARGARDT DISEASE PHENOTYPE.
Kuehlewein L; Hariri AH; Ho A; Dustin L; Wolfson Y; Strauss RW; Scholl HP; Sadda SR
Retina; 2016 Jun; 36(6):1216-21. PubMed ID: 26583307
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Short-Wavelength Reduced-Illuminance and Conventional Autofluorescence Imaging in Stargardt Macular Dystrophy.
Strauss RW; Muñoz B; Jha A; Ho A; Cideciyan AV; Kasilian ML; Wolfson Y; Sadda S; West S; Scholl HPN; Michaelides M
Am J Ophthalmol; 2016 Aug; 168():269-278. PubMed ID: 27296491
[TBL] [Abstract][Full Text] [Related]
3. Progression of Stargardt Disease as Determined by Fundus Autofluorescence in the Retrospective Progression of Stargardt Disease Study (ProgStar Report No. 9).
Strauss RW; Muñoz B; Ho A; Jha A; Michaelides M; Cideciyan AV; Audo I; Birch DG; Hariri AH; Nittala MG; Sadda S; West S; Scholl HPN;
JAMA Ophthalmol; 2017 Nov; 135(11):1232-1241. PubMed ID: 29049437
[TBL] [Abstract][Full Text] [Related]
4. Incidence of Atrophic Lesions in Stargardt Disease in the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: Report No. 5.
Strauss RW; Muñoz B; Ho A; Jha A; Michaelides M; Mohand-Said S; Cideciyan AV; Birch D; Hariri AH; Nittala MG; Sadda S; Scholl HPN;
JAMA Ophthalmol; 2017 Jul; 135(7):687-695. PubMed ID: 28542697
[TBL] [Abstract][Full Text] [Related]
5. ULTRAWIDEFIELD AUTOFLUORESENCE IN ABCA4 STARGARDT DISEASE.
Klufas MA; Tsui I; Sadda SR; Hosseini H; Schwartz SD
Retina; 2018 Feb; 38(2):403-415. PubMed ID: 28248825
[TBL] [Abstract][Full Text] [Related]
6. Semiautomated quantification of β-zone parapapillary atrophy using blue light fundus autofluorescence.
Mansouri K; Tung JD; Medeiros FA; Tafreshi A; Dorairaj S; Zangwill L; He F; Jain S; Weinreb RN
Acta Ophthalmol; 2013 Aug; 91(5):e379-385. PubMed ID: 23506312
[TBL] [Abstract][Full Text] [Related]
7. Multimodal analysis of the Preferred Retinal Location and the Transition Zone in patients with Stargardt Disease.
Verdina T; Greenstein VC; Sodi A; Tsang SH; Burke TR; Passerini I; Allikmets R; Virgili G; Cavallini GM; Rizzo S
Graefes Arch Clin Exp Ophthalmol; 2017 Jul; 255(7):1307-1317. PubMed ID: 28365912
[TBL] [Abstract][Full Text] [Related]
8. Quantifying the Rate of Ellipsoid Zone Loss in Stargardt Disease.
Cai CX; Light JG; Handa JT
Am J Ophthalmol; 2018 Feb; 186():1-9. PubMed ID: 29126757
[TBL] [Abstract][Full Text] [Related]
9. Automated Segmentation of Autofluorescence Lesions in Stargardt Disease.
Zhao PY; Branham K; Schlegel D; Fahim AT; Jayasundera KT
Ophthalmol Retina; 2022 Nov; 6(11):1098-1104. PubMed ID: 35644472
[TBL] [Abstract][Full Text] [Related]
10. A systematic comparison of spectral-domain optical coherence tomography and fundus autofluorescence in patients with geographic atrophy.
Sayegh RG; Simader C; Scheschy U; Montuoro A; Kiss C; Sacu S; Kreil DP; Prünte C; Schmidt-Erfurth U
Ophthalmology; 2011 Sep; 118(9):1844-51. PubMed ID: 21496928
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Blue-Light Autofluorescence and Ultrawidefield Green-Light Autofluorescence for Assessing Geographic Atrophy.
Abbasgholizadeh R; Habibi A; Emamverdi M; Ashrafkhorasani M; London N; Sinai MJ; Sinai EC; Sadda SR
Ophthalmol Retina; 2024 Apr; ():. PubMed ID: 38670262
[TBL] [Abstract][Full Text] [Related]
12. En Face Spectral-Domain Optical Coherence Tomography for the Monitoring of Lesion Area Progression in Stargardt Disease.
Melillo P; Testa F; Rossi S; Di Iorio V; Orrico A; Auricchio A; Simonelli F
Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT247-52. PubMed ID: 27409479
[TBL] [Abstract][Full Text] [Related]
13. Quantitative fundus autofluorescence in recessive Stargardt disease.
Burke TR; Duncker T; Woods RL; Greenberg JP; Zernant J; Tsang SH; Smith RT; Allikmets R; Sparrow JR; Delori FC
Invest Ophthalmol Vis Sci; 2014 May; 55(5):2841-52. PubMed ID: 24677105
[TBL] [Abstract][Full Text] [Related]
14. Atrophy Expansion Rates in Stargardt Disease Using Ultra-Widefield Fundus Autofluorescence.
Heath Jeffery RC; Thompson JA; Lo J; Lamey TM; McLaren TL; McAllister IL; Mackey DA; Constable IJ; De Roach JN; Chen FK
Ophthalmol Sci; 2021 Mar; 1(1):100005. PubMed ID: 36246008
[TBL] [Abstract][Full Text] [Related]
15. Fluorescence Lifetime Imaging in Stargardt Disease: Potential Marker for Disease Progression.
Dysli C; Wolf S; Hatz K; Zinkernagel MS
Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):832-41. PubMed ID: 26934141
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of autofluorescence imaging with the scanning laser ophthalmoscope and the fundus camera in age-related geographic atrophy.
Schmitz-Valckenberg S; Fleckenstein M; Göbel AP; Sehmi K; Fitzke FW; Holz FG; Tufail A
Am J Ophthalmol; 2008 Aug; 146(2):183-92. PubMed ID: 18514607
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Green Versus Blue Fundus Autofluorescence in
Müller PL; Pfau M; Mauschitz MM; Möller PT; Birtel J; Chang P; Gliem M; Schmitz-Valckenberg S; Fleckenstein M; Holz FG; Herrmann P
Transl Vis Sci Technol; 2018 Sep; 7(5):13. PubMed ID: 30279998
[TBL] [Abstract][Full Text] [Related]
18. [Contribution of multimodal imaging in the various stages of Stargardt disease].
El Matri L; Falfoul Y; Kortli M; Hassairi A; Charfi H; Turki A; Kort F; Chebil A
J Fr Ophtalmol; 2017 Oct; 40(8):666-675. PubMed ID: 28919188
[TBL] [Abstract][Full Text] [Related]
19. [Fundus autofluorescence imaging in patients with Stargardt dystrophy and fundus flavimaculatus].
Dolar-Szczasny J; Mackiewicz J; Biziorek B; Zagórski Z
Klin Oczna; 2007; 109(4-6):176-8. PubMed ID: 17725280
[TBL] [Abstract][Full Text] [Related]
20. Analysis of digital scanning laser ophthalmoscopy fundus autofluorescence images of geographic atrophy in advanced age-related macular degeneration.
Schmitz-Valckenberg S; Jorzik J; Unnebrink K; Holz FG;
Graefes Arch Clin Exp Ophthalmol; 2002 Feb; 240(2):73-8. PubMed ID: 11933894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
